Investors

A nerve cell affected by Alzheimer's disease
By  Dave Muoio 02:25 pm March 10, 2021
Yesterday Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, announced Phase 2 trial results suggesting its gamma frequency neuromodulation therapy slowed declines in memory and cognition among mild-to-moderate Alzheimer's disease patients. The OVERTURE study, a multi-center, randomized controlled trial, enrolled 76 such patients aged 50...
By  MobiHealthNews 03:01 pm March 9, 2021
Cedar, the maker of an intelligent patient billing and engagement platform, announced today a $200 million Series D round of funding headed by Tiger Global Management, with participation from prior backers including Andreessen Horowitz (a16z), Thrive Capital and Concord Health Partners. This brings the company's total fundraising haul to $350 million, it said, and its valuation to $3.2 billion....
By  Dave Muoio 01:34 pm March 9, 2021
Digital musculoskeletal (MSK) care triple-unicorn Hinge Health today announced the upcoming acquisition of Enso, the maker of an eponymous non-invasive electrical nerve stimulation device for pain relief. Hinge Health did not disclose the terms of the deal or its impact on Enso employees, but a representative told MobiHealthNews that the purchase is set to close "within weeks." The Enso device is...
Babylon by Telus
By  Laura Lovett 03:02 pm March 8, 2021
UK-based health chatbot Babylon Health is selling off its operations in Canada to former partner Telus Health in a licensing deal projected to be worth roughly $70 million, Business Insider reports. The pair previously inked a deal in 2019 to create Babylon by Telus Health, which allowed users to describe their symptoms to a text-based bot, consult with a provider via video, and store medical...
By  Dave Muoio 03:01 pm March 8, 2021
San Francisco-based behavioral health startup Ginger (formerly Ginger.io) has made two noteworthy additions to its advisory board: former U.S. Representative for Massachusetts Joe Kennedy III and Myrna Soto, the chief strategy and trust officer for cybersecurity company Forcepoint. "With a surge of people seeking care, and a growing shortage of those who provide it, our nation’s badly broken...
By  Dr. Mussaad M. Al-Razouki 12:23 pm March 5, 2021
The 2020s are on course to become the decade of the special purpose acquisition companies (SPACs), also known as "blank check" or "shell" companies. SPACs are set to outpace IPOs once again in 2021, after a record year that saw SPACs mature from a once obscure method of going public to a rabid, flavor-of-the-month frenzy amidst both institutional and retail investors. The year of COVID-19 saw 227...
Data science
By  Alaap B. Shah and Nivedita B. Patel 10:54 am March 5, 2021
In today’s world, data is power. Healthcare providers have massive amounts of rich health data at their fingertips. Yet historically, third-party vendors to healthcare providers often have derived financial benefits from secondary use of this data through aggregating and brokering de-identified data to downstream customers. That is beginning to change as healthcare providers are taking back...
By  Dave Muoio 03:21 pm March 4, 2021
No-cost medications for patients in need. Online prescription discount platform GoodRx has partnered with the National Association of Free and Charitable Clinics (NAFC) to kick off a philanthropic program that will support patients in need with free prescriptions and care. With a target goal of more than $5 million in free medications provided during 2021, the company said that it has kick-...
By  Dave Muoio 03:23 pm March 3, 2021
A January acquisition deal between medical technology provider Hillrom and cardiac monitoring device maker Bardy Diagnostics has landed in rocky waters, with Hillrom looking to back out of the purchase and Bardy filing a legal complaint to keep things moving forward. According to press releases from Hillrom, the company was caught off guard on January 29 when Novitas Solutions, a Medicare...
DispatchHealth
By  Laura Lovett 02:38 pm March 3, 2021
In-home care provider DispatchHealth scored a whopping $200 million in Series D financing. Tiger Global led the round with participation from Alta Partners, Echo Health Ventures, Humana, Oak HC/FT and Questa Capital. This investment bumps the company’s valuation to $1.7 billion, making it part of the ever-expanding unicorn club. In June the company closed its $138.5 million Series C funding. WHAT...